Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 13, 2024

SELL
$45.75 - $52.48 $686,250 - $787,200
-15,000 Reduced 22.69%
51,100 $8.94 Million
Q4 2023

Feb 14, 2024

SELL
$43.13 - $54.79 $5.42 Million - $6.88 Million
-125,600 Reduced 65.52%
66,100 $53.8 Million
Q3 2023

Nov 09, 2023

BUY
$50.95 - $55.2 $2.3 Million - $2.49 Million
45,100 Added 30.76%
191,700 $10.3 Million
Q2 2023

Aug 11, 2023

BUY
$50.45 - $57.18 $7.4 Million - $8.38 Million
146,600 New
146,600 $7.9 Million
Q4 2022

Feb 14, 2023

SELL
$38.86 - $48.55 $4.5 Million - $5.62 Million
-115,800 Reduced 91.11%
11,300 $34,000
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $4.73 Million - $12.8 Million
127,100 New
127,100 $51,000
Q1 2022

May 12, 2022

SELL
$48.48 - $53.65 $4.24 Million - $4.69 Million
-87,500 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $164,745 - $183,225
3,500 Added 4.17%
87,500 $36,000
Q3 2021

Nov 10, 2021

BUY
$47.89 - $53.12 $4.02 Million - $4.46 Million
84,000 New
84,000 $49,000
Q2 2021

Aug 11, 2021

SELL
$49.36 - $54.25 $547,896 - $602,175
-11,100 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$45.46 - $50.51 $922,838 - $1.03 Million
-20,300 Reduced 64.65%
11,100 $16,000
Q4 2020

Feb 16, 2021

BUY
$45.3 - $51.62 $217,440 - $247,776
4,800 Added 18.05%
31,400 $16,000
Q3 2020

Nov 13, 2020

BUY
$49.47 - $53.77 $1.32 Million - $1.43 Million
26,600 New
26,600 $24,000
Q1 2020

May 08, 2020

SELL
$38.02 - $51.66 $695,766 - $945,377
-18,300 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$44.25 - $50.86 $809,775 - $930,738
18,300 New
18,300 $43,000
Q3 2018

Nov 09, 2018

SELL
$40.0 - $44.84 $460,000 - $515,660
-11,500 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$37.63 - $41.22 $432,745 - $474,030
11,500 New
11,500 $6,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $130B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.